Prestige Consumer Healthcare Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $4.3 Billion | 1/10 | PBH $4.3B |
DCPH $2.2B |
SUPN $2.2B |
AMPH $1.5B |
ANIP $1.2B |
PCRX $1.2B |
PAHC $1.0B |
COLL $956.5M |
SSIC $66.7M |
EGRX $15.2M |
Gross Margin | 56% | 8/10 | PCRX 100% |
ANIP 100% |
SSIC 100% |
DCPH 92% |
SUPN 79% |
EGRX 74% |
COLL 61% |
PBH 56% |
AMPH 54% |
PAHC 32% |
Profit Margin | 19% | 4/10 | SSIC 67% |
SUPN 22% |
AMPH 21% |
PBH 19% |
EGRX 8% |
COLL 6% |
PAHC 3% |
ANIP -16% |
PCRX -85% |
DCPH -100% |
EBITDA margin | 32% | 2/10 | SSIC 147534% |
PBH 32% |
AMPH 30% |
SUPN 23% |
COLL 22% |
ANIP 20% |
EGRX 17% |
PAHC 10% |
PCRX -83% |
DCPH -105% |
Quarterly Revenue | $283.5 Million | 1/10 | PBH $283.5M |
PAHC $260.4M |
AMPH $188.8M |
SUPN $175.7M |
PCRX $168.6M |
COLL $159.3M |
ANIP $148.3M |
EGRX $64.6M |
DCPH $45.0M |
SSIC $1.9M |
Quarterly Earnings | $54.4 Million | 1/10 | PBH $54.4M |
AMPH $40.4M |
SUPN $38.5M |
COLL $9.3M |
PAHC $7.0M |
EGRX $5.2M |
SSIC $1.3M |
ANIP -$24.2M |
DCPH -$45.1M |
PCRX -$143.5M |
Quarterly Free Cash Flow | $67.8 Million | 1/10 | PBH $67.8M |
SUPN $53.3M |
PCRX $49.8M |
AMPH $46.2M |
ANIP $21.5M |
PAHC $3.0M |
SSIC $840,198 |
EGRX -$132,000 |
COLL -$9.2M |
DCPH -$54.7M |
Trailing 4 Quarters Revenue | $1.1 Billion | 1/10 | PBH $1.1B |
PAHC $1.0B |
AMPH $698.7M |
PCRX $695.0M |
SUPN $652.0M |
COLL $599.2M |
ANIP $555.5M |
EGRX $257.6M |
DCPH $174.9M |
SSIC $7.8M |
Trailing 4 Quarters Earnings | $205.9 Million | 1/10 | PBH $283.5M |
PAHC $260.4M |
AMPH $188.8M |
SUPN $175.7M |
PCRX $168.6M |
COLL $159.3M |
ANIP $148.3M |
EGRX $64.6M |
DCPH $45.0M |
SSIC $1.9M |
Quarterly Earnings Growth | 2% | 5/10 | SUPN 341% |
PAHC 187% |
EGRX 155% |
SSIC 128% |
PBH 2% |
DCPH 2% |
AMPH -18% |
COLL -55% |
ANIP -343% |
PCRX -1421% |
Annual Earnings Growth | -3% | 5/10 | SUPN 423% |
SSIC 352% |
COLL 49% |
AMPH 24% |
PBH -3% |
DCPH -4% |
PAHC -34% |
EGRX -87% |
ANIP -125% |
PCRX -203% |
Quarterly Revenue Growth | -1% | 9/10 | SSIC 77% |
DCPH 35% |
COLL 17% |
SUPN 14% |
ANIP 13% |
PAHC 13% |
AMPH 5% |
PCRX 3% |
PBH -1% |
EGRX -13% |
Annual Revenue Growth | -1% | 9/10 | SSIC 134% |
DCPH 23% |
SUPN 16% |
ANIP 15% |
AMPH 13% |
COLL 10% |
PAHC 5% |
PCRX 3% |
PBH -1% |
EGRX -39% |
Cash On Hand | $51.5 Million | 6/10 | PCRX $246.0M |
AMPH $192.1M |
ANIP $145.0M |
DCPH $91.2M |
PAHC $51.8M |
PBH $51.5M |
COLL $39.0M |
SUPN $31.7M |
SSIC $29.8M |
EGRX $15.4M |
Short Term Debt | $2.7 Million | 8/10 | COLL $65.9M |
SUPN $9.2M |
PCRX $9.2M |
EGRX $8.3M |
ANIP $7.2M |
AMPH $4.5M |
DCPH $3.6M |
PBH $2.7M |
PAHC -$0 |
SSIC -$0 |
Long Term Debt | $1.1 Billion | 1/10 | PBH $1.1B |
COLL $808.5M |
AMPH $625.4M |
ANIP $618.2M |
PCRX $480.3M |
PAHC $287.7M |
EGRX $61.9M |
SUPN $28.9M |
DCPH $21.4M |
SSIC $0 |
PE | 20.69 | 3/10 | PAHC 59.97 |
SUPN 36.17 |
PBH 20.69 |
SSIC 12.36 |
COLL 10.80 |
AMPH 9.46 |
EGRX 0.97 |
PCRX -1.00 |
ANIP -1.00 |
DCPH -1.00 |
PS | 3.84 | 3/10 | DCPH 12.65 |
SSIC 8.60 |
PBH 3.84 |
SUPN 3.31 |
ANIP 2.23 |
AMPH 2.13 |
PCRX 1.69 |
COLL 1.60 |
PAHC 1.00 |
EGRX 0.06 |
PB | 2.46 | 5/10 | DCPH 7.00 |
COLL 4.08 |
PAHC 4.04 |
ANIP 2.87 |
PBH 2.46 |
SUPN 2.14 |
AMPH 2.05 |
PCRX 1.57 |
SSIC 0.75 |
EGRX 0.06 |
PC | 82.66 | 1/10 | PBH 82.66 |
SUPN 68.19 |
COLL 24.55 |
DCPH 24.26 |
PAHC 20.14 |
ANIP 8.54 |
AMPH 7.76 |
PCRX 4.78 |
SSIC 2.24 |
EGRX 0.99 |
Liabilities to Equity | 0.92 | 6/10 | COLL 5.98 |
PAHC 2.74 |
ANIP 2.11 |
AMPH 1.12 |
PCRX 1.03 |
PBH 0.92 |
EGRX 0.61 |
SUPN 0.33 |
DCPH 0.33 |
SSIC 0.00 |
ROA | 0.06 | 2/10 | AMPH 10% | PBH 6% | SSIC 6% | COLL 5% | SUPN 4% | EGRX 4% | PAHC 2% | ANIP -1% | PCRX -6% | DCPH -45% |
ROE | 0.12 | 3/10 | COLL 38% |
AMPH 22% |
PBH 12% |
PAHC 7% |
SUPN 6% |
EGRX 6% |
SSIC 6% |
ANIP -2% |
PCRX -12% |
DCPH -60% |
Current Ratio | 2.09 | 4/10 | DCPH 4.01 |
SUPN 4.00 |
EGRX 2.65 |
PBH 2.09 |
PCRX 1.97 |
AMPH 1.89 |
ANIP 1.50 |
PAHC 1.37 |
COLL 1.17 |
SSIC -1.00 |
Quick Ratio | 0.03 | 9/10 | PAHC 59.97 |
SUPN 36.17 |
PBH 20.69 |
SSIC 12.36 |
COLL 10.80 |
AMPH 9.46 |
EGRX 0.97 |
PCRX -1.00 |
ANIP -1.00 |
DCPH -1.00 |
Long Term Debt to Equity | 0.61 | 6/10 | COLL} 3.45 |
ANIP} 1.52 |
PAHC} 1.11 |
AMPH} 0.86 |
PCRX} 0.64 |
PBH} 0.61 |
EGRX} 0.25 |
DCPH} 0.07 |
SUPN} 0.03 |
SSIC} 0.00 |
Debt to Equity | 0.61 | 6/10 | COLL 3.73 |
ANIP 1.54 |
PAHC 1.11 |
AMPH 0.87 |
PCRX 0.65 |
PBH 0.61 |
EGRX 0.28 |
DCPH 0.08 |
SUPN 0.03 |
SSIC 0.00 |
Burn Rate | -4.53 | 7/10 | PAHC 11.44 |
ANIP 2.86 |
DCPH 1.95 |
PCRX 1.49 |
COLL 0.99 |
SUPN -0.90 |
PBH -4.53 |
AMPH -13.44 |
SSIC -23.41 |
EGRX -25.01 |
Cash to Cap | 0.01 | 9/10 | EGRX 1.01 |
SSIC 0.45 |
PCRX 0.21 |
AMPH 0.13 |
ANIP 0.12 |
PAHC 0.05 |
COLL 0.04 |
DCPH 0.04 |
PBH 0.01 |
SUPN 0.01 |
CCR | 1.25 | 2/10 | SUPN 1.39 |
PBH 1.25 |
DCPH 1.21 |
AMPH 1.14 |
SSIC 0.66 |
PAHC 0.44 |
EGRX -0.03 |
PCRX -0.35 |
ANIP -0.89 |
COLL -0.99 |
EV to EBITDA | 58.87 | 1/10 | PBH} 58.87 |
ANIP} 58.77 |
SUPN} 52.81 |
COLL} 51.44 |
PAHC} 47.75 |
AMPH} 33.82 |
EGRX} 6.51 |
SSIC} 0.01 |
PCRX} -10.16 |
DCPH} -45.43 |
EV to Revenue | 4.75 | 3/10 | DCPH 12.27 |
SSIC 4.76 |
PBH 4.75 |
SUPN 3.31 |
ANIP 3.09 |
COLL 2.99 |
AMPH 2.76 |
PCRX 2.04 |
PAHC 1.22 |
EGRX 0.27 |